Effect of Atogepant on Migraine-Specific Quality of Life Questionnaire and Headache Impact Test-6 in a 12-Week, Double-blind, Randomized, Phase 3 (PROGRESS) Trial for Preventive Treatment of Chronic Migraine

被引：0

作者：

Lipton, Richard B. ^{[1
]}

Pozo-Rosich, Patricia ^{[2
,3
]}

Dodick, David W. ^{[4
]}

Christie, Suzanne ^{[5
]}

Ailani, Jessica ^{[6
]}

Nagy, Krisztian ^{[7
]}

Stokes, Jonathan ^{[8
]}

Guo, Hua ^{[8
]}

Gandhi, Pranav ^{[8
]}

机构：

[1] Albert Einstein Coll Med, Bronx, NY USA

[2] Vall dHebron Univ Hosp, Barcelona, Spain

[3] Univ Autonoma Barcelona, Headache Res Grp, VHIR, Barcelona, Spain

[4] Mayo Clin, Dept Neurol, Scottsdale, AZ USA

[5] Univ Ottawa, Neurol, Ottawa, ON, Canada

[6] MedStar Georgetown Univ Hosp, Washington, DC USA

[7] AbbVie, Budapest, Hungary

[8] AbbVie, Madison, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MTIS22-PO-

引用

页码：87 / 89

页数：3

共 32 条